As the debate around the UK REACH Alternative Transitional Registration Model (ATRm) enters another political season, industry engagement continues to intensify. The Alliance of Chemical Associations has again taken the case directly to Westminster through conference-season articles in The House magazine, while the Chemical Business Association hosted a parliamentary reception in September alongside further ministerial engagement and correspondence with the Prime Minister.

What is striking is that, after years of discussion, the fundamental disagreement is no longer about chemical safety.

Industry supports chemical safety. Businesses support understanding hazards, assessing risks, communicating safe use information and protecting workers, consumers and the environment. The UK's chemical sector already operates to some of the highest regulatory standards in the world.

The real question is much simpler:

Why are duplicated UK registrations necessary when the underlying science already exists and the UK intends to align with EU regulatory decisions in most cases?

Defra continues to defend ATRm as essential to maintaining a robust UK REACH system. However, many of the arguments being advanced by Government appear to reinforce industry's case rather than answer its concerns.

"Companies need hazard, use and exposure information to manage chemicals safely."

Absolutely.

The difficulty with this argument is that companies already possess and use that information today. The hazard data was generated under EU REACH and continues to underpin the safe manufacture, supply and use of chemicals across Europe and the UK. Businesses rely on it daily to produce classifications, safety data sheets and risk management measures.

ATRm does not generate new scientific knowledge. It does not identify new hazards. It does not improve understanding of chemical risks.

It simply requires much of the same information to be reported again through a separate UK process.

"Businesses already have duties under CLP and supply chain legislation, so REACH registration should not create new problems."

Again, industry agrees.

Indeed, if businesses are already meeting their obligations under GB CLP legislation, preparing Safety Data Sheets and communicating risks throughout their supply chains, then it becomes difficult to identify the additional safety benefit that ATRm delivers.

Defra itself points to these existing legal duties when defending the practicality of the system. Yet the existence of those duties arguably strengthens the case that safe chemical management is already being achieved through mechanisms that businesses routinely use and understand.

The question therefore remains: what new protection is being created by requiring a second registration exercise?

"Industry must understand its chemicals."

No one is suggesting otherwise.

The chemicals sector has consistently accepted that manufacturers, importers and downstream users must understand the substances they place on the market and manage associated risks responsibly.

However, understanding chemicals and recreating regulatory dossiers are not the same thing.

The debate is not about whether businesses should understand their substances. The debate is about whether they should be required to reconstruct information packages that already exist within another mature regulatory system.

"ATRm reduces costs by 70%."

Reducing the cost of duplication does not justify duplication.

Defra estimates that ATRm will significantly reduce the costs associated with replicating EU REACH registrations. Industry recognises this as an improvement on earlier proposals and welcomes efforts to reduce unnecessary burden.

However, the central question is not whether duplication is cheaper than it once was.

It is whether duplication is necessary at all.

If a process imposes substantial costs without delivering corresponding additional safety benefits, reducing those costs does not address the underlying concern. The issue is not the size of the bill. It is why the bill exists in the first place.

"The UK needs its own information to manage chemicals."

This is perhaps the most difficult argument to reconcile with recent Government policy.

The Government has made clear that UK REACH will increasingly look to decisions made by trusted jurisdictions, particularly the European Union, and that alignment with EU restrictions and authorisations is expected unless there are compelling reasons to diverge.

If the UK intends to follow EU regulatory outcomes in the vast majority of cases, many businesses struggle to understand why a parallel UK registration database is required.

The challenge for Defra is not demonstrating that information is important. Everyone agrees that it is.

The challenge is explaining why information that already exists, and which underpins decisions the UK intends largely to follow, must be recreated at considerable expense within a separate national system.

A Question Still Waiting for an Answer

The chemicals sector is not arguing against regulation. Nor is it arguing against chemical safety.

Rather, businesses are asking for a proportionate system that avoids unnecessary duplication while maintaining the high standards of protection that both industry and regulators support.

That question remains unanswered.

Until Government can clearly articulate the additional safety, environmental or regulatory benefits created specifically by duplicated UK registrations, industry is likely to continue asking why hundreds of millions of pounds should be spent recreating information that already exists and is already being used safely.

As parliamentary engagement increases during the autumn conference season, that fundamental question is unlikely to disappear. If anything, it is becoming more difficult to ignore.